
Member of the European Parliament · Spain EPP
Dolors Montserrat
MEP for Spain · European People's Party · Partido Popular · official EP profile
As of 14 September 2026, Dolors Montserrat (EPP, Spain) has declared 40 lobby meetings this term - rank 409 of 719 MEPs by declared meetings.
That is somewhat below the Parliament average of 85 meetings per MEP, and 108 of 185 within European People's Party.
77% of this MEP's declared counterpart entries, including diplomatic and government entries, carry a declared EU Transparency Register link - above the like-for-like raw Parliament-wide share of 51%.
Compare with the rest: search and sort all 719 MEPs, or see every MEP from Spain.
Compared with the averages
Transparency this term
Monthly declared meetings (bars) and the share of all counterpart entries carrying a declared Register link, including diplomatic and government entries (line), July 2024 to September 2026. This is the same current-term window as the figures above, beginning 16 July 2024.
Current month, partial through 11 Sep 2026: 0 declared meetings in Sep 2026. Peak: 9 in Oct 2024.
Busiest month: 9 declared in October 2024. Months with no declared meetings have no Register-share value.
Who Dolors Montserrat meets most
Counterparts are merged by resolved Transparency Register identity where possible. An entry counts as register-linked above only when the MEP declaration itself carries a Register link.
Where the meetings cluster
Most-met sectors
Health & pharma (26), Transport & automotive (3), Agriculture & food (1)
Meetings by committee topic
Public Health (21), Environment, Climate and Food Safety (18), Economic and Monetary Affairs (1)
Most recent declared meetings
| Date | Counterpart | Capacity | Subject |
|---|---|---|---|
| 19 Mar 2026 | Airbus ↗ | Member | European aviation industry future |
| 17 Mar 2026 | International Air Transport Association ↗ | Member | European Air Transportations |
| 28 Jan 2026 | Meta Platforms Ireland Limited and its various subsidiaries ↗ | Member | AI Act and Digital legislation |
| 26 Nov 2025 | Almirall; MEDICINES FOR EUROPE ↗; European Federation of Pharmaceutical Industries and Associations | Rapporteur | Review of the EU General Pharmaceutical Legislation |
| 25 Nov 2025 | Pharmaceutical Group of the European Union ↗ | Rapporteur | Review of the EU General Pharmaceutical Legislation |
| 6 Nov 2025 | Pharmaceutical Group of the European Union ↗ | Rapporteur | Review of the EU General Pharmaceutical Legislation |
| 17 Oct 2025 | Teva Pharmaceuticals Europe BV ↗ | Rapporteur | Review of the EU General Pharmaceutical Legislation |
| 14 Oct 2025 | Aboca S.p.a. Società Agricola ↗ | Rapporteur | Review of the EU General Pharmaceutical Legislation |
| 10 Sep 2025 | MEDICINES FOR EUROPE ↗ | Rapporteur | Revision of the EU Pharmaceutical Directive |
| 4 Sep 2025 | Association of the European Self-Care Industry ↗ | Rapporteur | Revision of the EU Pharmaceutical Directive |
Show 20 more meetings
| Date | Counterpart | Capacity | Subject |
|---|---|---|---|
| 16 Jul 2025 | Biocat, Fundació BioRegió de Catalunya ↗ | Member | EU Biotechnologies hubs on Health |
| 8 Jul 2025 | Gilead Sciences ↗ | Rapporteur | Review of the EU General Pharmaceutical Legislation |
| 1 Jul 2025 | Teva Pharmaceuticals Europe BV | Rapporteur | General Pharmaceutical Legislation Review |
| 25 Jun 2025 | European Federation of Pharmaceutical Industries and Associations | Rapporteur | General Pharmaceutical Legislation Review |
| 20 Jun 2025 | MEDICINES FOR EUROPE | Rapporteur | General Pharmaceutical Legislation Review |
| 11 Jun 2025 | GSK | Rapporteur | General Pharmaceutical Legislation Review |
| 5 Jun 2025 | PIMEC - Asociación de Micro, Pequeñas y Medianas Empresas de Cataluña | Member | Measures for Small and medium sized enterprises, and small mid-cap enterprises |
| 26 May 2025 | Gilead Sciences ↗ | Member | Cancer treatments and HIV vaccines |
| 26 May 2025 | Merck ↗ | Rapporteur | New EU Pharmaceutical Legislation |
| 1 Apr 2025 | Affordable Medicines Europe ↗ | Rapporteur | New EU Pharmaceutical Legislation |
| 28 Mar 2025 | MEDICINES FOR EUROPE ↗ | Member | Urban Waste Water Treatment Directive |
| 20 Mar 2025 | HIPRA, S.A. ↗ | Member | Vaccines and the EU preparedness strategy to Health crisis |
| 19 Mar 2025 | Novo Nordisk A/S ↗; European Federation of Pharmaceutical Industries and Associations ↗ | Rapporteur | New EU Pharmaceutical Legislation |
| 17 Mar 2025 | Cosmetics Europe ↗ | Member | Current situation of the cosmetic industry in the EU |
| 3 Dec 2024 | Bayer AG ↗ | Rapporteur | New EU Pharmaceutical Legislation |
| 19 Nov 2024 | EUROPEAN ORGANISATION FOR RARE DISEASES ↗ | Member | Rare Diseases incidence in Europe |
| 19 Nov 2024 | ANFAC - Spanish Association of Automobile and Truck Manufacturers | Member | Crisis of the European Automotive Sector |
| 18 Nov 2024 | Medical Leaflets Patient Safety | Rapporteur | New EU Pharmaceutical Legislation |
| 24 Oct 2024 | MEDICINES FOR EUROPE ↗ | Rapporteur | New EU Pharmaceutical Legislation |
| 23 Oct 2024 | European Diabetes Forum ↗ | Member | Diabetes prevention and impact in the EU |
The full record is in the official EP declarations.
Roll-call voting record
Recorded votes only. Parliament held 5,568 roll-call votes while Dolors Montserrat held the seat, 537 of them the final vote on a text. A member with no vote recorded may have been on parliamentary business, ill, on leave, or present without voting - the published record does not distinguish these and gives no reason. Votes taken by show of hands or by secret ballot are not recorded by name and are absent here.
How they voted on final texts
Share of the 537 final votes held while seated.
With and against the group
On the 486 final texts where more than half of EPP members casting a vote went one way, and Dolors Montserrat also voted. Groups are not bound to vote together: a Member's mandate is personal and exercised freely, so neither figure is a measure of performance.
Final texts where Dolors Montserrat differed from the EPP majority
| Date | Text | Their vote | EPP majority |
|---|---|---|---|
| 7 July 2026 | A10-0187/2026 – Lukas Mandl, Pierfrancesco Maran – Motion for a resolution (as a whole) | Abstained | For |
| 17 June 2026 | A10-0166/2026 – Riho Terras – Motion for a resolution (as a whole) | Against | For |
| 16 June 2026 | A10-0147/2026 – Lukas Mandl – Motion for a resolution (as a whole) | Abstained | For |
| 21 May 2026 | A10-0121/2026 – Isabella Lövin – Motion for a resolution (as a whole) | Abstained | For |
| 29 April 2026 | A10-0098/2026 – Danuše Nerudová – Commission proposal | Abstained | For |
| 29 April 2026 | A10-0042/2026 – Anna Strolenberg – Motion for a resolution (as a whole) | Abstained | For |
| 28 April 2026 | A9-0147/2022 – Bernd Lange – Commission proposal | Against | For |
| 12 February 2026 | A10-0010/2026 – Lina Gálvez – Motion for a resolution (as a whole) | Abstained | For |
| 12 February 2026 | A10-0256/2025 – Johan Danielsson – Motion for a resolution (as a whole) | Against | For |
| 26 November 2025 | B10-0503/2025 – Motion for a resolution | For | Against |
10 further instances are not listed. All roll-call votes.
Unlinked but matchable
5 counterpart entrys in Dolors Montserrat's declarations appear to match an EU Transparency Register entry without being linked in the declaration:
- “European Federation of Pharmaceutical Industries and Associations” - likely European Federation of Pharmaceutical Industries and Associations (2 counterpart entrys)
- “Almirall” - likely Almirall (1 counterpart entry)
- “MEDICINES FOR EUROPE” - likely MEDICINES FOR EUROPE (1 counterpart entry)
Matching is automated and can be wrong - see how matching works. Linking the register entry is the fix, and it is the MEP office's to make.